Incyte Cash Flow Statement
NASDAQ: INCYHealth CareBiotechnology: Commercial Physical & Biological ResarchUSD
112.79+0.04 (+0.04%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Incyte free cash flow
In fiscal 2025, Incyte generated $1.41 billion of operating cash flow. That left free cash flow of $1.41 billion, a free-cash-flow margin of 27.5% of revenue. Free cash flow was up 321.5% from the prior year's $335.3 million.
Summary generated from market data by MetaCap's automated system. Methodology
Incyte cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 1.29B | 32.62M | 597.60M | 340.66M | 948.58M | -295.70M | 446.91M | 109.49M | -313.14M | 104.22M |
| Net Income growth (YoY) | +3844.96% | -94.54% | +75.42% | -64.09% | — | -166.17% | +308.16% | — | -400.46% | +1495.80% |
| Depreciation & Amortization | 93.29M | 89.25M | 82.66M | 67.86M | 57.84M | 51.81M | 54.53M | 54.97M | 52.18M | 58.42M |
| Stock-Based Compensation | 249.35M | 266.06M | 215.89M | 188.42M | 183.01M | 177.88M | 166.59M | 148.15M | 133.06M | 96.20M |
| Change in Working Capital | -527.16M | 138.24M | -248.65M | 198.81M | -14.57M | -71.74M | 57.30M | -46.54M | -64.23M | 37.27M |
| Operating Cash Flow | 1.41B | 335.34M | 496.49M | 969.94M | 749.49M | -124.60M | 710.66M | 336.23M | -92.99M | 304.76M |
| Capital Expenditures | — | — | — | -77.83M | -181.01M | -187.38M | -78.06M | -73.48M | -111.02M | -120.28M |
| Investing Cash Flow | -102.61M | 157.52M | -207.68M | -78.54M | -207.70M | -269.00M | -87.45M | -86.42M | -349.98M | -232.49M |
| Share Repurchases | 0 | -2.00B | 0 | 0 | — | — | — | — | — | — |
| Financing Cash Flow | 101.04M | -2.02B | -20.03M | -794.00K | 6.18M | 71.71M | 45.71M | 14.66M | 690.21M | 44.62M |
| Net Change in Cash | 1.41B | -1.53B | 262.10M | 893.96M | 544.39M | -318.94M | 668.72M | 264.55M | 247.21M | 116.88M |
| Free Cash Flow | 1.41B | 335.34M | 496.49M | 892.11M | 568.48M | -311.98M | 632.59M | 262.74M | -204.01M | 184.48M |
This table shows 10 annual periods of Incyte's cash flow statement, from FY 2025 back to FY 2016, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow INCY's reporting calendar. What is a cash flow statement?